The smart Trick of keytruda triple negative breast cancer That Nobody is Discussing
Keytruda is often a brand (trade) name for pembrolizumab. It is actually given by intravenous infusion every a few to 6 weeks. Rarely, the use of Keytruda results from the immune system attacking healthier tissues and this can cause severe side effects for example pneumonitis, colitis, or hepatitis. In some people, using Keytruda has resulted withi